Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab
Merck Pharmaceuticals from Germany and Takeda Pharmaceuticals from Japan to colloborate in marketing of Merck's cancer drug Matuzumab.
Matuzumab is developed by Merck which is in its Phase II // clinical tiral. Takeda Pharmaceuticals will sign agreement with Merck to give royalty and sale be...
Double binding sites on tumor target may provide future combination therapy
...r other types of cancer. An additional drug called matuzumab
is in phase II clinical trials.
Three years ago...s found again using X-ray crystallography -- that matuzumab
binds in a different place from Erbitux. Their bin...has important implications for the clinical use of matuzumab
and for developing new therapies that target EGFR....
Matuzumab in Medical Technology
Matuzumab in other areas